Back
Intellia Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Sell
5
NTLA
Intellia Therapeutics
Last Price:
$12.20
Seasonality Move:
-3.92%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Sell
5
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
-
The current Intellia Therapeutics [NTLA] share price is $12.21. The Score for NTLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $12.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.91 | Sell |
Relative Strength Index (14 RSI): | 34.7 | Sell |
Chaikin Money Flow: | 734391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13 - 14.98) | Sell |
Bollinger Bands (100): | (14.92 - 22.24) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.51 | Sell |
Relative Strength Index (14 RSI): | 24.55 | Sell |
Chaikin Money Flow: | 64911 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.57 - 111.43) | Sell |
Bollinger Bands (100): | (107.18 - 131.16) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.92 | Sell |
20-day SMA: | 14.03 | Sell |
50-day SMA: | 15.6 | Sell |
200-day SMA: | 21.65 | Sell |
8-day EMA: | 12.86 | Sell |
20-day EMA: | 13.76 | Sell |
50-day EMA: | 15.52 | Sell |
200-day EMA: | 21.32 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.03 | Sell |
20-day SMA: | 106.85 | Sell |
50-day SMA: | 109.33 | Sell |
200-day SMA: | 126.14 | Sell |
8-day EMA: | 102.09 | Sell |
20-day EMA: | 105.65 | Sell |
50-day EMA: | 110.06 | Sell |
200-day EMA: | 118.01 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.19 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Intellia Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |